Thursday, the FDA approved Bausch + Lomb and Novaliq’s perfluorohexyloctane ophthalmic solution, now to be marketed as Miebo, to treat symptoms of dry eye disease.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,